Rothschild Investment LLC’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Rothschild Investment LLC’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,800	Closed	-$223K	–	395
2019 Q2	$223K	Buy	+2,800	New	+$251K	0.03%	350
2019 Q1	–	Sell	-1,990	Closed	-$201K	–	383
2018 Q4	$201K	Hold	1,990	–	–	0.03%	343
2018 Q3	$251K	Sell	1,990 -2,500	-56%	-$265K	0.03%	326
2018 Q2	$377K	Sell	4,490 -674	-13%	-$49.4K	0.05%	271
2018 Q1	$318K	Hold	5,164	–	–	0.04%	289
2017 Q4	$302K	Sell	5,164 -682	-12%	-$43K	0.03%	338
2017 Q3	$339K	Buy	5,846 +1,054	+22%	+$114K	0.04%	319
2017 Q2	$580K	Hold	4,792	–	–	0.07%	263
2017 Q1	$542K	Buy	4,792 +2,040	+74%	+$238K	0.06%	268
2016 Q4	$299K	Buy	2,752 +100	+4%	+$11.9K	0.04%	341
2016 Q3	$436K	Hold	2,652	–	–	0.05%	281
2016 Q2	$378K	Hold	2,652	–	–	0.05%	307
2016 Q1	$341K	Hold	2,652	–	–	0.04%	323
2015 Q4	$396K	Hold	2,652	–	–	0.05%	309
2015 Q3	$440K	Buy	2,652 +460	+21%	+$101K	0.06%	299
2015 Q2	$529K	Hold	2,192	–	–	0.06%	293
2015 Q1	$618K	Hold	2,192	–	–	0.07%	264
2014 Q4	$342K	Buy	+2,192	New	+$405K	0.04%	347

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rothschild Investment LLC's ICPT Position: Q3 2019 in Review

Rothschild Investment LLC sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2019, closing a stake of 2,800 shares — an estimated $223K sold.

Rothschild Investment LLC first reported a position in ICPT in Q4 2014 and held it in 18 quarters. The position peaked at $618K in Q1 2015. 188 funds tracked by Wall St. Rank hold ICPT as of Q3 2019.

Rothschild Investment LLC reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Rothschild Investment LLC sold 2,800 Intercept Pharmaceuticals, Inc. shares in Q3 2019, an estimated $223K.
Rothschild Investment LLC first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 18 quarters.
Rothschild Investment LLC's Intercept Pharmaceuticals, Inc. position peaked at $618K in Q1 2015.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2019.

Based on Rothschild Investment LLC's 13F filing for Q3 2019, filed 11 Oct 2019.